10.11.2022

Verunreinigungen in Arzneimitteln - Fokus Nitrosamine

In this conference you will get to know the relevant aspects regarding nitrosamines in drug substances and drug products. Dr. Hiltrud Horn will update you on latest requirements for EU and US and discuss what needs to be considered for API and drug product manufacturers including biologics. Specific aspects of packaging material will also be addressed. She will inform you about latest EU and US-implementation timelines for nitrosamines. In addition, a practical example of risk assessment is presented.

For more information please visit the following website:

(Conference organized by FORUM Institut )



Back

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

  • 25.08.2022
    Online Seminar: Prozessvalidierung - Aktuelle Anforderungen an CMC-Daten
    More
  • 10.11.2022
    Verunreinigungen in Arzneimitteln - Fokus Nitrosamine
    More
  • 15.11.2022
    MEGRA StartUp
    More
Get all events



News

  • 16.05.2022
    New Clinical Trials Regulation and new IMPD-Guidelines in place
    More
  • 29.10.2020
    Latest Guidances regarding Nitrosamine Impurities
    More
  • 18.05.2020
    Impact of COVID-19 pandemic on Pharma: GMP and Regulatory Flexibility
    More
Get all news